Tianyi Medical: New product Phosphate/Bicarbonate Hemodiafiltration Solution obtains drug registration certificate.

Tianyi Medical announced that its subsidiary, Ningbo Tianyi Pharmaceutical Technology Co., Ltd., recently received a "Drug Registration Certificate" issued by the National Medical Products Administration. The drug is called Phosphate/Bicarbonate Sodium Hemofiltration Replacement Solution, with main ingredients including magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride, and disodium hydrogen phosphate. It is an injection with a specification of 5000ml, registered as a Class 4 chemical drug. The drug approval number is H20263849, valid until April 6, 2031. This product is used in continuous renal replacement therapy to supplement replacement fluids, correct patient internal environment imbalances, and specifically prevent and correct hypophosphatemia.